• Dietary intake and nutritional status in patients with newly diagnosed inflammatory bowel disease: insights from the IBSEN III study 

      Zerouga, Insaf; Valeur, Jørgen; Sommer, Christine; Småstuen, Milada Cvancarova; Medhus, Asle Wilhelm; Lund, Charlotte; Johansen, Ingunn; Boyar Cetinkaya, Raziye; Bengtson, May-Bente; Torp, Roald; Hovde, Øistein; Huppertz-Hauss, Gert; Detlie, Trond Espen; Aabrekk, Tone Bergene; Ricanek, Petr; Frigstad, Svein Oskar; Hopstock, Laila Arnesdatter; Opheim, Randi; Kristensen, Vendel Ailin; Høivik, Marte Lie; Carlsen, Monica Hauger; Aas, Anne-Marie (Scandinavian Journal of Gastroenterology;, Peer reviewed; Journal article, 2024)
      Background: Dietary recommendations in inflammatory bowel disease (IBD) are inconclusive, and patients may follow restrictive diets with increased risk of malnutrition. The aim of this study was to compare dietary intakes ...
    • Switching from intravenous to subcutaneous vedolizumab maintenance treatment in patients with inflammatory bowel disease followed by therapeutic drug monitoring 

      Wiken, Thea H.; Høivik, Marte Lie; Buer, Lydia Celine Tansem; Warren, David J.; Bolstad, Nils; Moum, Bjørn Allan; Anisdahl, Karoline; Småstuen, Milada Cvancarova; Medhus, Asle Wilhelm (Peer reviewed; Journal article, 2023)
      Objective: Vedolizumab (VDZ) for subcutaneous (SC) administration has recently become available. We aimed to assess feasibility, safety and clinical outcome when switching from intravenous (IV) to SC VDZ maintenance ...